A multicenter retrospective study on clinical characteristics, treatment patterns, and outcome in elderly patients with hepatocellular carcinoma

Oncologist

Volumn 16, Issue 3, 2011, Pages 310-318

  Kozyreva, Olga N ^a   Chi, Dorcas ^a   Clark, Jeffrey W ^b   Wang, Hejing ^c   Theall, Kathy P ^a   Ryan, David P ^b   Zhu, Andrew X ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Elderly; Epidemiology; Hepatocellular carcinoma; Survival; Treatment pattern

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; ELDERLY CARE; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ONCOLOGICAL PARAMETERS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT PLANNING;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79953002209     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2010-0223     Document Type: Article

References (33)

1. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009;27:1485-1491.
2. Lok AS, Seeff LB, Morgan TR et al; HALT-C Trial Group. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology. 2009;136:138-148.
3. Sarbah SA, Gramlich T, Younoszai A et al. Risk factors for hepatocellular carcinoma in patients with cirrhosis. Dig Dis Sci 2004;49:850-853.
4. N'Kontchou G, Paries J, Htar MT et al. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis. Clin Gastroenterol Hepatol 2006;4:1062-1068.
5. Horner MJ, Ries LAG, Krapcho M et al. SEER Cancer Statistics Review, 1975-2006. Bethesda, MD: National Cancer Institute. Available at http://seer.cancer.gov/csr/1975_2006/. Accessed December 1, 2009.
6. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004;127:S27-S34.
7. Armstrong GL, Wasley A, Simard EP et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006;144:705-714.
8. Bouchardy C, Rapiti E, Blagojevic S et al. Older female cancer patients: importance, causes, and consequences of undertreatment. J Clin Oncol 2007;25:1858-1869.
9. Gross CP, Smith BD, Wolf E et al. Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002? Cancer 2008;112:900-908.
10. Hazama H, Omagari K, Matsuo I et al. Clinical features and treatment of hepatocellular carcinoma in eight patients older than eighty years of age. Hepatogastroenterology 2001;48:1692-1696.
11. Dohmen K, Shirahama M, Shigematsu H et al. Optimal treatment strategy for elderly patients with hepatocellular carcinoma. J Gastroenterol Hepatol 2004;19:859-865.
12. Kaibori M, Matsui K, Ishizaki M et al. Hepatic resection for hepatocellular carcinoma in the elderly. J Surg Oncol 2009;99:154-160.
13. Nomura F, Ohnishi K, Honda M et al. Clinical features of hepatocellular carcinoma in the elderly: a study of 91 patients older than 70 years. Br J Cancer 1994;70:690-693.
14. Poon RT, Fan ST, Lo CM et al. Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol 1999; 94:2460-2466.
15. Hoshida Y, Ikeda K, Kobayashi M et al. Chronic liver disease in the extremely elderly of 80 years or more: clinical characteristics, prognosis and patient survival analysis. J Hepatol 1999;31:860-866.
16. Zhou L, Rui JA, Wang SB et al. Clinicopathological features, post-surgical survival and prognostic indicators of elderly patients with hepatocellular carcinoma. Eur J Surg Oncol 2006;32:767-772.
17. Fujishima T, Ishikawa T, Shiratori Y et al. Age-related comparison of the profiles of patients with hepatocellular carcinoma. Hepatogastroenterology 2006;53:913-918.
18. Fernández-Ruiz M, Guerra-Vales JM, Llenas-García J et al. Hepatocellular carcinoma in the elderly: clinical characteristics, survival analysis, and prognostic indicators in a cohort of Spanish patients older than 75 years. Rev Esp Enferm Dig 2008;100:625-631.
19. Pignata S, Gallo C, Daniele B et al. Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly.Astudy of the Cancer of the Liver Italian Program (CLIP). Crit Rev Oncol Hematol 2006;59: 243-249.
20. Bruix J, Sherman M, Llovet JM et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 2001;35:421-430.
21. Balducci L. Geriatric oncology: challenges for the new century. Eur J Cancer 2000;36:1741-1754.
22. Jing-Lin X, Sharma D, Bing-Hui Y et al. Analysis of the clinicopathological features of hepatocellular carcinoma in elderly patients. J Nepal Med Assoc 2008;47:132-135.
23. Huang J, Li BK, Chen GH et al. Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy. J Gastrointest Surg 2009;13:1627-1635.
24. Tsukioka G, Kakizaki S, Sohara N et al. Hepatocellular carcinoma in extremely elderly patients: an analysis of clinical characteristics, prognosis and patient survival. World J Gastroenterol 2006;12:48-53.
25. Thornton RH, Covey A, Petre EN et al. A comparison of outcomes from treating hepatocellular carcinoma by hepatic artery embolization in patients younger or older than 70 years. Cancer 2009;115:5000-5006.
26. Paulozzi L, Annest J. Unintentional poisoning deaths-United States, 1999-2004. CDC. MMWR 2007;56:93-96.
27. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999;19:329-338.
28. Marrero JA, Fontana RJ, Barrat A et al. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 2005;41:707-715.
29. The Organ Procurement and Transplantation Network. Available at http://optn.transplant.hrsa.gov/latestData/rpt. Accessed December 1, 2009.
30. Sanyal AJ, Moyneur E, Barghout V. Retrospective claims database analysis of elderly compared with nonelderly patients (pts) with newly diagnosed hepatocellular carcinoma (HCC). J Clin Oncol 2009;27:abstract 9552.
31. Townsley CA, Chan KK, Pond GR et al. Understanding the attitudes of the elderly towards enrolment into cancer clinical trials. BMC Cancer 2006;6: 34-34.
32. Hanazaki K, Kajikawa S, Shimozawa N et al. Hepatic resection for hepatocellular carcinoma in the elderly. J Am Coll Surg 2001;192:38-46.
33. Mirici-Cappa F, Gramenzi A, Santi V et al. Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20- year multicentre experience. Gut 2010;59:387-396.